tiprankstipranks
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market
Holding IN:AUROPHARMA?
Track your performance easily

Aurobindo Pharma Ltd (AUROPHARMA) Stock Price & Analysis

0 Followers

AUROPHARMA Stock Chart & Stats


AUROPHARMA FAQ

What was Aurobindo Pharma Ltd’s price range in the past 12 months?
Aurobindo Pharma Ltd lowest stock price was ₹959.05 and its highest was ₹1592.55 in the past 12 months.
    What is Aurobindo Pharma Ltd’s market cap?
    Aurobindo Pharma Ltd’s market cap is ₹703.84B.
      When is Aurobindo Pharma Ltd’s upcoming earnings report date?
      Aurobindo Pharma Ltd’s upcoming earnings report date is Feb 14, 2025 which is in 14 days.
        How were Aurobindo Pharma Ltd’s earnings last quarter?
        Aurobindo Pharma Ltd released its earnings results on Nov 09, 2024. The company reported ₹14 earnings per share for the quarter, missing the consensus estimate of ₹16.046 by -₹2.046.
          Is Aurobindo Pharma Ltd overvalued?
          According to Wall Street analysts Aurobindo Pharma Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Aurobindo Pharma Ltd pay dividends?
            Aurobindo Pharma Ltd pays a Notavailable dividend of ₹1.5 which represents an annual dividend yield of 0.37%. See more information on Aurobindo Pharma Ltd dividends here
              What is Aurobindo Pharma Ltd’s EPS estimate?
              Aurobindo Pharma Ltd’s EPS estimate is 15.54.
                How many shares outstanding does Aurobindo Pharma Ltd have?
                Aurobindo Pharma Ltd has 580,801,640 shares outstanding.
                  What happened to Aurobindo Pharma Ltd’s price movement after its last earnings report?
                  Aurobindo Pharma Ltd reported an EPS of ₹14 in its last earnings report, missing expectations of ₹16.046. Following the earnings report the stock price went up 1.522%.
                    Which hedge fund is a major shareholder of Aurobindo Pharma Ltd?
                    Currently, no hedge funds are holding shares in IN:AUROPHARMA
                    ---

                    AUROPHARMA Stock 12 Month Forecast

                    Average Price Target

                    ₹1,366.67
                    ▲(18.13% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1025":"₹1,025","1554":"₹1,554","1157.25":"₹1,157.3","1289.5":"₹1,289.5","1421.75":"₹1,421.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1475,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.48K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1366.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.37K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.23K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1025,1157.25,1289.5,1421.75,1554],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Jan<br/>2025","25":"Jan<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1351.4,1360.9076923076923,1370.4153846153847,1379.923076923077,1389.4307692307693,1398.9384615384615,1408.446153846154,1417.9538461538461,1427.4615384615386,1436.9692307692308,1446.4769230769232,1455.9846153846154,1465.4923076923078,{"y":1475,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1351.4,1352.5746153846155,1353.749230769231,1354.9238461538462,1356.0984615384616,1357.273076923077,1358.4476923076925,1359.6223076923077,1360.7969230769231,1361.9715384615386,1363.146153846154,1364.3207692307692,1365.4953846153846,{"y":1366.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1351.4,1341.6769230769232,1331.9538461538461,1322.2307692307693,1312.5076923076924,1302.7846153846153,1293.0615384615385,1283.3384615384616,1273.6153846153848,1263.8923076923077,1254.1692307692308,1244.446153846154,1234.7230769230769,{"y":1225,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1068.96,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1026.5,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1112.65,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1152.45,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1187,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1212.15,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1432.25,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1553.2,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1438.55,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1396,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1255.25,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1351.4,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1351.4,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Cipla Ltd
                    Dr. Reddy's Laboratories Ltd.
                    Lupin Limited
                    Sun Pharmaceutical Industries Limited
                    Torrent Pharmaceuticals Ltd

                    Best Analysts Covering AUROPHARMA

                    1 Year
                    Shyam SrinivasanGoldman Sachs
                    1 Year Success Rate
                    0/1 ratings generated profit
                    0%
                    1 Year Average Return
                    -3.50%
                    reiterated a buy rating 21 days ago
                    Copying Shyam Srinivasan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.50% per trade.
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis